Literature DB >> 20159553

Swe1Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function.

Mehdi Mollapour1, Shinji Tsutsumi, Alison C Donnelly, Kristin Beebe, Mari J Tokita, Min-Jung Lee, Sunmin Lee, Giulia Morra, Dimitra Bourboulia, Bradley T Scroggins, Giorgio Colombo, Brian S Blagg, Barry Panaretou, William G Stetler-Stevenson, Jane B Trepel, Peter W Piper, Chrisostomos Prodromou, Laurence H Pearl, Len Neckers.   

Abstract

Saccharomyces WEE1 (Swe1), the only "true" tyrosine kinase in budding yeast, is an Hsp90 client protein. Here we show that Swe1(Wee1) phosphorylates a conserved tyrosine residue (Y24 in yeast Hsp90 and Y38 in human Hsp90alpha) in the N domain of Hsp90. Phosphorylation is cell-cycle associated and modulates the ability of Hsp90 to chaperone a selected clientele, including v-Src and several other kinases. Nonphosphorylatable mutants have normal ATPase activity, support yeast viability, and productively chaperone the Hsp90 client glucocorticoid receptor. Deletion of SWE1 in yeast increases Hsp90 binding to its inhibitor geldanamycin, and pharmacologic inhibition/silencing of Wee1 sensitizes cancer cells to Hsp90 inhibitor-induced apoptosis. These findings demonstrate that Hsp90 chaperoning of distinct client proteins is differentially regulated by specific posttranslational modification of a unique subcellular pool of the chaperone, and they provide a strategy to increase the cellular potency of Hsp90 inhibitors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20159553      PMCID: PMC2824606          DOI: 10.1016/j.molcel.2010.01.005

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  54 in total

1.  Hsp90 phosphorylation is linked to its chaperoning function. Assembly of the reovirus cell attachment protein.

Authors:  Y G Zhao; R Gilmore; G Leone; M C Coffey; B Weber; P W Lee
Journal:  J Biol Chem       Date:  2001-07-03       Impact factor: 5.157

Review 2.  Structure and mechanism of the Hsp90 molecular chaperone machinery.

Authors:  Laurence H Pearl; Chrisostomos Prodromou
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

3.  Hsp90: from structure to phenotype.

Authors:  Sophie E Jackson; Christine Queitsch; David Toft
Journal:  Nat Struct Mol Biol       Date:  2004-12       Impact factor: 15.369

4.  The function and regulation of budding yeast Swe1 in response to interrupted DNA synthesis.

Authors:  Hong Liu; Yanchang Wang
Journal:  Mol Biol Cell       Date:  2006-03-29       Impact factor: 4.138

5.  Putting the heat on cancer.

Authors:  Paul Workman; Emmanuel de Billy
Journal:  Nat Med       Date:  2007-12       Impact factor: 53.440

6.  Structural and functional analysis of the middle segment of hsp90: implications for ATP hydrolysis and client protein and cochaperone interactions.

Authors:  Philippe Meyer; Chrisostomos Prodromou; Bin Hu; Cara Vaughan; S Mark Roe; Barry Panaretou; Peter W Piper; Laurence H Pearl
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

7.  Post-translational modification of heat-shock protein 90: impact on chaperone function.

Authors:  Bradley T Scroggins; Len Neckers
Journal:  Expert Opin Drug Discov       Date:  2007-10       Impact factor: 6.098

Review 8.  Heat shock protein 90: the cancer chaperone.

Authors:  Len Neckers
Journal:  J Biosci       Date:  2007-04       Impact factor: 1.826

Review 9.  The morphogenesis checkpoint: how yeast cells watch their figures.

Authors:  Daniel J Lew
Journal:  Curr Opin Cell Biol       Date:  2003-12       Impact factor: 8.382

10.  Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15.

Authors:  C H McGowan; P Russell
Journal:  EMBO J       Date:  1993-01       Impact factor: 11.598

View more
  83 in total

1.  Alternative approaches to Hsp90 modulation for the treatment of cancer.

Authors:  Jessica A Hall; Leah K Forsberg; Brian S J Blagg
Journal:  Future Med Chem       Date:  2014-09       Impact factor: 3.808

Review 2.  HSP90 at the hub of protein homeostasis: emerging mechanistic insights.

Authors:  Mikko Taipale; Daniel F Jarosz; Susan Lindquist
Journal:  Nat Rev Mol Cell Biol       Date:  2010-06-09       Impact factor: 94.444

3.  Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment.

Authors:  Hardik J Patel; Shanu Modi; Gabriela Chiosis; Tony Taldone
Journal:  Expert Opin Drug Discov       Date:  2011-05       Impact factor: 6.098

4.  HSP90 functions in the circadian clock through stabilization of the client F-box protein ZEITLUPE.

Authors:  Tae-sung Kim; Woe Yeon Kim; Sumire Fujiwara; Jeongsik Kim; Joon-Yung Cha; Jin Ho Park; Sang Yeol Lee; David E Somers
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

Review 5.  Post-translational modifications of Hsp90 and translating the chaperone code.

Authors:  Sarah J Backe; Rebecca A Sager; Mark R Woodford; Alan M Makedon; Mehdi Mollapour
Journal:  J Biol Chem       Date:  2020-06-11       Impact factor: 5.157

Review 6.  Toxoplasma gondii Hsp90: potential roles in essential cellular processes of the parasite.

Authors:  Sergio O Angel; Maria J Figueras; Maria L Alomar; Pablo C Echeverria; Bin Deng
Journal:  Parasitology       Date:  2014-02-21       Impact factor: 3.234

Review 7.  Exploiting replicative stress to treat cancer.

Authors:  Matthias Dobbelstein; Claus Storgaard Sørensen
Journal:  Nat Rev Drug Discov       Date:  2015-05-08       Impact factor: 84.694

8.  Ligand-independent activation of the P2X7 receptor by Hsp90 inhibition stimulates motor neuron apoptosis.

Authors:  Amy L Strayer; Cassandra N Dennys-Rivers; Karina C Ricart; Narae Bae; Joseph S Beckman; Maria Clara Franco; Alvaro G Estevez
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-29

Review 9.  The HSP90 chaperone machinery.

Authors:  Florian H Schopf; Maximilian M Biebl; Johannes Buchner
Journal:  Nat Rev Mol Cell Biol       Date:  2017-04-21       Impact factor: 94.444

10.  Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors.

Authors:  Mehdi Mollapour; Dimitra Bourboulia; Kristin Beebe; Mark R Woodford; Sigrun Polier; Anthony Hoang; Raju Chelluri; Yu Li; Ailan Guo; Min-Jung Lee; Elham Fotooh-Abadi; Sahar Khan; Thomas Prince; Naoto Miyajima; Soichiro Yoshida; Shinji Tsutsumi; Wanping Xu; Barry Panaretou; William G Stetler-Stevenson; Gennady Bratslavsky; Jane B Trepel; Chrisostomos Prodromou; Len Neckers
Journal:  Mol Cell       Date:  2014-01-23       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.